Beginning Cash: The amount of cash reported by the company on its previous statement.
Caris Life Sciences,�Inc. (CAI) had Beginning Cash of $800.04M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$216.17M |
|
$-0.51M |
|
$74.83M |
|
$141.35M |
|
$210.89M |
|
$5.28M |
|
$-5.93M |
|
$-0.64M |
|
$-0.64M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$-0.51M |
|
$5.28M |
|
$12.97M |
|
282.56M |
|
282.56M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$1.01B |
|
$82.67M |
|
$148.21M |
|
$1.16B |
|
$143.90M |
|
$381.40M |
|
$425.00M |
|
$568.90M |
|
$593.49M |
|
$574.15M |
|
$593.49M |
|
282.65M |
|
| Cash Flow Statement Financials | |
$32.88M |
|
$-10.34M |
|
$0.82M |
|
|
Beginning Cash |
$800.04M |
$823.39M |
|
$23.35M |
|
$15.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.05 |
|
-- |
|
-- |
|
0.39 |
|
0.64 |
|
65.39% |
|
2.44% |
|
2.44% |
|
-- |
|
-0.30% |
|
-0.24% |
|
$22.53M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.98 |
|
2.39 |
|
37.69 |
|
-0.09% |
|
-0.09% |
|
-0.04% |
|
-0.05% |
|
$2.10 |
|
$0.08 |
|
$0.12 |
|